Parasympathomimetic Medications
- PMID: 32119421
- Bookshelf ID: NBK554534
Parasympathomimetic Medications
Excerpt
Parasympathomimetics are a class of medications that activate the parasympathetic nervous system by mimicking or modifying the effects of acetylcholine. These drugs include muscarinic receptor agonists (direct-acting parasympathomimetics) and acetylcholinesterase inhibitors (indirect-acting parasympathomimetics). This activity reviews the indications, contraindications, activity, adverse events, and other key elements of parasympathomimetic therapy in the clinical setting pertinent to interprofessional team members managing the care of patients receiving these medications.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010 Jul 28;304(4):452-60. - PubMed
-
- Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000 Jan;161(1):309-29. - PubMed
-
- Bonner LT, Peskind ER. Pharmacologic treatments of dementia. Med Clin North Am. 2002 May;86(3):657-74. - PubMed
-
- Pascuzzi RM. The edrophonium test. Semin Neurol. 2003 Mar;23(1):83-8. - PubMed
-
- Nilsson E. Physostigmine treatment in various drug-induced intoxications. Ann Clin Res. 1982 Aug;14(4):165-72. - PubMed
Publication types
LinkOut - more resources
Full Text Sources